MedPath

Testing of boosting capacity of Shancol, a killed whole cell oral cholera vaccine,in previously vaccinated children and adults .

Phase 2
Completed
Registration Number
CTRI/2012/04/002574
Lead Sponsor
International Vaccine Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
426
Inclusion Criteria

All subjects must be presently enrolled in the Phase 3 NICED RCT of Shanchol• and satisfy the following criteria at study entry:

1.Male or female adults aged 6 years and above, who are available for follow-up visits and specimen collection.

a.The subject should be able to continue in the study for the next 6 weeks

b.The subject (or parent/guardian) should be willing to provide 3 blood samples

2.Written informed consent obtained from the subjects or their parents/guardians, and written assent obtained from children aged 12 â?? 17 years.

3.Healthy subjects as determined by:

a.Medical history

b.Physical examination

c.Clinical judgment of the investigator

Exclusion Criteria

1. Individuals who are too weak to get out of bed to receive the vaccine;

2.Pregnant women (identified through verbal screening);

3.Those less than 6 years of age; and

4.Receipt of cholera vaccine following 2009 (time of licensure and availability of Shanchol•India)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath